Sk Life Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SK LIFE, and when can generic versions of SK LIFE drugs launch?
SK LIFE has one approved drug.
There are two US patents protecting SK LIFE drugs.
There are twenty-three patent family members on SK LIFE drugs in twenty countries and eleven supplementary protection certificates in ten countries.
Summary for Sk Life
| International Patents: | 23 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Sk Life
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-004 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-002 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-004 | Mar 10, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-001 | Mar 10, 2020 | RX | Yes | Yes | 11,654,133 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-006 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-001 | Mar 10, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Sk Life Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2007143073 | ⤷ Try a Trial |
| South Korea | 20080005437 | ⤷ Try a Trial |
| Russian Federation | 2418792 | ⤷ Try a Trial |
| South Korea | 101286499 | ⤷ Try a Trial |
| Mexico | 2007013197 | ⤷ Try a Trial |
| Netherlands | 301106 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sk Life Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1879873 | CR 2021 00015 | Denmark | ⤷ Try a Trial | PRODUCT NAME: CENOBAMAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1530 20210330 |
| 1879873 | 19/2021 | Austria | ⤷ Try a Trial | PRODUCT NAME: CENOBAMAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1530 (MITTEILUNG) 20210330 |
| 1879873 | 301106 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: CENOBAMAAT OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/21/1530 20210330 |
| 1879873 | CA 2021 00015 | Denmark | ⤷ Try a Trial | PRODUCT NAME: CENOBAMAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1530 20210330 |
| 1879873 | 21C1027 | France | ⤷ Try a Trial | PRODUCT NAME: CENOBAMATE OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/21/1530 20210330 |
| 1879873 | 2021C/524 | Belgium | ⤷ Try a Trial | PRODUCT NAME: CENOBAMAAT; AUTHORISATION NUMBER AND DATE: EU/1/21/1530 20210330 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
